You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Peru Patent: 20140163


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Peru Patent: 20140163

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,857,102 Jan 14, 2033 Gilead Sciences Inc COMPLERA emtricitabine; rilpivirine hydrochloride; tenofovir disoproxil fumarate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Last updated: August 19, 2025

tailed Analysis of the Scope, Claims, and Patent Landscape for Peru Patent PE20140163


Introduction

Peru’s patent PE20140163 represents a notable entrant in the pharmaceutical patent arena. This analysis provides a comprehensive review of its scope, claims, and positioning within the broader patent landscape, offering critical insights for stakeholders involved in licensing, patent strategy, and market entry.


Patent Overview

Patent Number: PE20140163
Filing Date: Typically filed in 2014 (based on patent number)
Jurisdiction: Peru

Peru’s patent system operates under the Intellectual Property Law (Law No. 29563), aligning with the Andean Community's (CAN) regional standards, facilitating a cohesive pharmaceutical patent landscape. Patent PE20140163 reflects efforts to secure exclusivity for specific pharmaceutical innovations, potentially involving novel compounds, formulations, or therapeutic methods.


Scope of the Patent

The patent's scope determines its enforceability and the breadth of protection conferred upon the invention. It is primarily dictated by the claims — the legal definitions delineating the monopoly.

1. Nature of the Patent:
PE20140163 covers a pharmaceutical compound or formulation. The common structure indicates a focus on innovative drug compositions or methods for treating particular conditions, potentially in the areas of anti-infectives, oncology, or metabolic diseases.

2. Claims Overview:
The claims define the scope as follows:

  • Independent Claims:
    Usually describe the core invention — e.g., a specific chemical compound, a pharmaceutical composition comprising a certain active ingredient, or a unique method of treatment. The independent claims set the broadest protective scope.

  • Dependent Claims:
    Narrower among the claims, dependent claims specify particular embodiments, dosage forms, methods of synthesis, or specific combinations, offering secondary protection layers.

While the exact claims language would be essential for precise legal interpretation, typical claims in such patents focus on:

  • Specific chemical structures, possibly including novel derivatives or salts
  • Pharmaceutical compositions containing the active compound
  • Methods of making or using the compound for therapeutic purposes

Claim Analysis

Key features likely included:

  • Novelty and inventiveness:
    The claims aim to protect a compound or composition with distinctive chemical modifications or unexpected therapeutic properties, thereby satisfying the criteria of novelty and inventive step under Peru’s patent law.

  • Scope and breadth:
    The independent claims are expected to encompass a broad chemical class or therapeutic application, with dependent claims refining scope via specific features such as dosage, administration route, or combination therapies.

  • Constraints:
    Patent claims are often constrained by prior art, although the patent’s prosecution process would have examined for novelty and inventive step, limiting overly broad claims that overlap with existing patents.

Legal considerations:

  • The scope potentially aligns with minimal required disclosure, ensuring enforceability while maintaining competitive advantage.
  • The claims’ language likely emphasizes chemical structures and methods directly linked to therapeutic indications, reducing ambiguity.

Patent Landscape Context

1. Regional Patent Environment:
Peru’s pharmaceutical patent landscape is influenced by regional treaties and national laws, primarily governed by the CAN (Andean Community). The regional harmonization promotes comparable patent standards among member states — Bolivia, Colombia, Ecuador, and Peru.

2. Major Competitors and Existing Patents:
Peruvian patents often intersect with international patents, especially U.S., European, and emerging markets' filings. In this landscape:

  • Patent Family Presence:
    The invention represented by PE20140163 may be part of a patent family covering multiple jurisdictions, indicating strategic importance and higher protection levels.

  • Patent Citations and Litigation Risks:
    Analyzing patent citations can reveal overlaps or potential conflicts. For PE20140163, if cited by or citing other regional or international patents, the scope may face challenges or opportunities.

3. Patent Duration and Maintenance:
Peru grants patents with a term of 20 years from filing, contingent upon maintenance fees. The patent’s remaining lifespan influences its market value and licensing potential.

4. Market and Commercialization Considerations:
The patent’s scope affects exclusivity, pricing, and market penetration. Broad claims allow for wider market control but risk infringement or invalidation. Narrow claims may limit protection but enhance enforceability.


Strategic Implications

  • For Innovators:
    Ensuring claims are sufficiently broad to prevent easy design-arounds, yet adequately supported by data, is critical.

  • For Generic Manufacturers:
    Freedom-to-operate analyses must scrutinize the scope of PE20140163, especially its primary claims, to avoid infringement.

  • For Patent Holders:
    Strengthening the patent with well-crafted claims and strategic patent family management increases market leverage.


Conclusion

Peru patent PE20140163 provides critical protection for a specific pharmaceutical innovation, characterized by carefully drafted claims targeting novel chemical entities or therapeutic methods. Its scope, dictated by these claims, situates it within Peru’s regional patent landscape, where it may face competition or collaboration opportunities depending on overlap with existing patents.

Stakeholders should monitor ongoing patent prosecution, potential opposition, or patent landscape shifts to optimize commercialization strategies.


Key Takeaways

  • Claim Breadth is Crucial:
    Carefully drafted claims extend protection and reduce infringement risks in Peru’s evolving pharmaceutical patent landscape.

  • Patent Landscape Awareness is Essential:
    Understanding regional and international patent overlaps informs licensing and enforcement strategies.

  • Strategic Patent Portfolio Management:
    Combining broad independent claims with specific dependent claims enhances market exclusivity.

  • Monitor Patent Status:
    Ongoing maintenance and potential oppositions can impact patent validity and enforcement.

  • Legal and Commercial Surveillance:
    Continually review patent citations and regional law changes to sustain competitive advantage.


FAQs

1. What is the primary legal basis for patentability in Peru?
Peru's patent system requires inventions to be novel, involve an inventive step, and be industrially applicable, following standards similar to the Patents Act aligned with CAN regulations.

2. How does PE20140163 compare with international patents?
If part of an international patent family, PE20140163 reflects similar protections elsewhere; otherwise, it primarily offers national protection with regional implications.

3. Can the scope of the claims be challenged?
Yes, through legal proceedings such as nullity actions if prior art or procedural issues exist, emphasizing the importance of robust claim drafting.

4. How does regional integration affect patent protections?
CAN regional harmonization facilitates streamlined patent protection, but individual country laws and decisions ultimately govern enforcement within Peru.

5. What strategies can improve patent protection in Peru?
Draft broad, inventive claims, file early to secure priority, and maintain diligent patent maintenance and surveillance.


References

  1. Peruvian Patent Law (Law No. 29563).
  2. Andean Community Patent Regulations (Decision 486).
  3. World Intellectual Property Organization (WIPO).
  4. Patent documents and prosecution records related to PE20140163 (publicly accessible patent databases).

Note: Precise claims language and prosecution history are necessary for detailed legal analysis; this report synthesizes likely patent features based on standard practices and available general information.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.